| Elizabeth Frances Behling, MS CF- SLP | |
|
480 E Division St, Fond Du Lac, WI 54935-3734 | |
| (920) 929-2300 | |
| Not Available |
| Full Name | Elizabeth Frances Behling |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 480 E Division St, Fond Du Lac, Wisconsin |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1558048603 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Elizabeth Frances Behling, MS CF- SLP 430 E Division St, Fond Du Lac, WI 54935-4560 Ph: (920) 926-5370 | Elizabeth Frances Behling, MS CF- SLP 480 E Division St, Fond Du Lac, WI 54935-3734 Ph: (920) 929-2300 |
News Archive
The researchers show that the mice immunized with homotypic or mosaic nanoparticles produced broad binding and neutralizing responses, in contrast to plasma antibodies elicited in humans by SARS-CoV-2 infection. The RBD nanoparticles induced cross-reactive IgG responses in the immunized mice.
Medtronic plc announced FDA approval and U.S. launch of the Intellis(TM) platform for the management of certain types of chronic intractable pain. The Intellis platform was designed to overcome limitations with current spinal cord stimulation (SCS) systems, such as battery performance, and can power the EvolveSM workflow*, which standardizes guidance and balances high-dose (HD) and low-dose (LD) therapy settings.
Complete Genomics, a third-generation human genome sequencing company, today announced publication of a report in the journal Science describing its proprietary DNA sequencing platform, including analysis of sequence data from three complete human genomes. The consumables cost for these three genomes sequenced on the proof-of-principle genomic DNA nanoarrays ranged from $8,005 for 87x coverage to $1,726 for 45x coverage for the samples described in this report.
A recent study discusses the efficacy of an AI-enhanced ECG technique that has been used to diagnose left ventricular dysfunction in COVID-19 patients.
› Verified 3 days ago
Kerry A Winget, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 430 E Division St, Fond Du Lac, WI 54935 Phone: 920-923-5378 | |
Kendalyn Susan Voss, Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 420 E Division St, Fond Du Lac, WI 54935 Phone: 920-929-2300 | |
Linda Vande Zande, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 244 N Macy St, Fond Du Lac, WI 54935 Phone: 920-926-0050 | |
Mrs. Lisa Marie Coulter, MS-CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 115 E Arndt St, Fond Du Lac, WI 54935 Phone: 920-923-7054 Fax: 920-923-7058 | |
Angeleen Dodge, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 500 N Park Ave, Fond Du Lac, WI 54935 Phone: 920-929-8858 Fax: 920-923-3038 | |
Monica Garvey Krueger, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 115 E Arndt St, Fond Du Lac, WI 54935 Phone: 920-923-7040 | |
Michelle Lynn Halfman, MS CCC SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 845 S Main St, Fond Du Lac, WI 54935 Phone: 920-322-0447 |